These emerging therapies , Semaglutide , represent a groundbreaking advancement in managing metabolic dysfunction and possibly associated conditions . They are grouped as GLP-1 receptor activators , indicating these substances to mimic the natural GLP-1 substance , boosting metabolic production and suppressing hunger . While Tirzepatide each one… Read More